Search
Simulations Plus Inc
SLPAdd to Watchlist
18.230USD
-0.070-0.38%
Close 07-31 16:00（ET）Quotes delayed by 15 min
368.70MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Simulations Plus Inc is 6.00, ranking 172 out of 199 in the Healthcare Equipment & Supplies industry. The average price target is 22.50, with a high of 31.00 and a low of 16.00.
Analyst Rating
Based on
5
analysts
Hold
Current Rating
19.833
Target Price
+8.80%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Simulations Plus Inc
SLP
5
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
33
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
30
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Simulations Plus Inc's expected revenue for the next quarter?
Simulations Plus Inc's expected revenue is 17.66M.
What is Simulations Plus Inc's price target?
Analysts forecast that Simulations Plus Inc's price target is USD 22.50, with the highest forecast at USD 31.00 and the lowest forecast at USD 16.00.
How have Simulations Plus IncSLP's recent earnings per share performed?
The market expectation was USD 0.18, while Simulations Plus IncSLP's earnings per share (EPS) for the previous quarter was USD 0.22. EPS for the next quarter is expected at USD 0.04.
What is the analyst rating for Simulations Plus Inc?
Based on the ratings of Simulations Plus Inc's stock from 5 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.